These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19287036)

  • 1. Cutaneous mast cell tumours in dogs.
    Polton G
    Vet Rec; 2009 Mar; 164(11):345. PubMed ID: 19287036
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous mast cell tumours in dogs.
    Kupfer J
    Vet Rec; 2010 Mar; 166(13):407-8. PubMed ID: 20348476
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study.
    Brocks BA; Neyens IJ; Teske E; Kirpensteijn J
    Vet Surg; 2008 Jul; 37(5):472-8. PubMed ID: 18986315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable treatment for mast cell tumours in dogs.
    Vet Rec; 2020 Oct; 187(7):e56. PubMed ID: 32747483
    [No Abstract]   [Full Text] [Related]  

  • 5. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours.
    Jaffe MH; Hosgood G; Kerwin SC; Hedlund CS; Taylor HW
    J Small Anim Pract; 2000 Jan; 41(1):7-11. PubMed ID: 10713976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
    Weisse C; Shofer FS; Sorenmo K
    J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
    Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
    J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.
    Brière C
    Can Vet J; 2002 Aug; 43(8):620-2. PubMed ID: 12170840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.
    Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ
    Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of canine mast cell tumors to treatment with oral prednisone.
    McCaw DL; Miller MA; Ogilvie GK; Withrow SJ; Brewer WG; Klein MK; Bell FW; Anderson SK
    J Vet Intern Med; 1994; 8(6):406-8. PubMed ID: 7884726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic mast cell tumour in a dog presenting with spinal pain.
    Cooper MA; Bennett PF; Laverty PH
    Aust Vet J; 2009 Apr; 87(4):157-9. PubMed ID: 19335472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-agent chemotherapy for mast cell tumours in the dog.
    Gerritsen RJ; Teske E; Kraus JS; Rutteman GR
    Vet Q; 1998 Jan; 20(1):28-31. PubMed ID: 9477533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid leucaemia in a dog after chemotherapy for mast cell sarcomas.
    Steel RJ
    Aust Vet J; 1989 Apr; 66(4):108-9. PubMed ID: 2499300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell tumour destruction in dogs by hypotonic solution.
    Grier RL; Di Guardo G; Myers R; Merkley DF
    J Small Anim Pract; 1995 Sep; 36(9):385-8. PubMed ID: 8583766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
    Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
    J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deionised water and mast cell tumours.
    Grier RL; Di Guardo G
    J Small Anim Pract; 2000 Aug; 41(8):368-71. PubMed ID: 11002942
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.
    Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P
    J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.